| Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC) V Khanna, H Kim, W Zhang, P Larson, M Shah, TS Griffith, D Ferguson, ... Scientific reports 11 (1), 3346, 2021 | 22 | 2021 |
| Combination of STING and TLR 7/8 agonists as vaccine adjuvants for cancer immunotherapy S Bhatnagar, V Revuri, M Shah, P Larson, Z Shao, D Yu, S Prabha, ... Cancers 14 (24), 6091, 2022 | 11 | 2022 |
| HFB200603, a novel anti-BTLA monoclonal antibody that provides therapeutic potential for immune escape and synergizes with anti-PD-1 treatment J Li, Q Zhang, B Shen, M Shah, M Chen, S Li, L Dong, F Adrian, ... Presented at the AACR, 2022 | 1 | 2022 |
| CD4 T Cell–Derived IL-21 Is Critical for Sustaining Plasmodium Infection–Induced Germinal Center Responses and Promoting the Selection of Memory B Cells with Recall Potential JT Johnson, FA Surette, GR Ausdal, M Shah, AM Minns, SE Lindner, ... The Journal of Immunology, 2024 | | 2024 |
| Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 2022, 14, 6091 S Bhatnagar, V Revuri, M Shah, P Larson, Z Shao, D Yu, S Prabha, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Combination of STING and TLR 7/8 agonists as vaccine adjuvants for cancer immunotherapy MC Shah University of Minnesota, 2021 | | 2021 |
